Anbio Biotechnology

NNNN - CIK 0001982708

Market cap$1.50 B

Rank#2315

SEC filings40

NNNN income statement (quarterly)

No parsed quarterly data available for Anbio Biotechnology yet.

NNNN annual revenue (10-K history)

Anbio Biotechnology reported annual revenue of $8.65M for fiscal year 2025. That is up 5.6% from $8.19M in fiscal 2024. Figures come from the company's audited annual reports as filed with the SEC.

Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.